Emergence of the ‘first-titled’ domestic vaccines attracted the depressed domestic market
2 vaccines, titled as the ‘first’ in the domestic market, appeared.
One of them is GSK’s ‘Fluarix Tetra,’ a tetravalent flu vaccine called as the next-generation vaccine. A number of tetravalent vaccines have been launched globally, but it is the only product approved in Korea.
Another one is S...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
